Benjamin Netanyahu, the Prime Minister of Israel, has been diagnosed with benign prostate enlargement (BPH), which led to a urinary tract infection requiring medical attention. The details of his condition, particularly the size of the prostate enlargement, have not been publicly disclosed. However, it's known that this health issue necessitated surgical intervention, with Netanyahu scheduled for a prostate removal surgery on December 29, 2024. The specific measurements or extent of the prostate's enlargement are typically not shared in public health announcements unless they directly impact public policy or health discussions.
 

News reports confirm that Netanyahu was treated with antibiotics for his urinary tract infection, a common approach to manage such conditions stemming from prostate issues. The decision to proceed with surgery suggests that the enlargement was significant enough to warrant this course of action to avoid future complications, which is often the case with BPH in older men. Despite this, the precise medical details, including the size of the prostate, remain private, as is standard with personal health information.
 

While the public is aware of Netanyahu's health challenge, the exact specifics of his prostate enlargement size are not part of the public discourse. This is in line with maintaining the privacy of medical records unless they have significant public implications. Netanyahu's health situation has been managed to ensure he can continue his duties with minimal disruption, with the surgery planned to safeguard his long-term health. The focus has been on his recovery and the implications for his role rather than on the clinical details of his condition.